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Introduction: Previous observations indicate that the presubiculum accumulates 
amyloidogenic proteins in a range of diseases, but only minimal neurofibrillary 
degeneration is seen. However, in the neighbouring entorhinal cortex and subiculum 
severe neuronal loss and deposition of amyloid plaques is observed. Using post-
mortem brain samples from AD cases, we aimed to characterise the protein deposits 
and determine the level of microglial activation in both the presubiculum and the 
neighbouring areas.  
Materials and Methods: Immunohistochemistry was performed on sporadic AD 
(n=19) and familial AD (n=11) cases in order to visualise the presubiculum and the 
entorhinal cortex. The density of amyloid, tau and microglial staining present in both 
areas was assessed. Amyloid deposits from the presubiculum and the entorhinal 
cortex were laser captured for biochemical analysis.  
Results: Significantly less tau and microglial activation was observed in the 
presubiculum compared to the entorhinal cortex in both AD groups. Neurofibrillary 
tangles were absent in the presubiculum. However, resting microglial levels were 
closer to equal in both areas in both groups. Mass spectrometry analysis revealed 
there were less N-terminally truncated and pyro-glutamate modified amyloid peptides 
in the presubiculum compared to the entorhinal cortex.  
Conclusion: We have shown that the presubiculum has different pathological 
characteristics in a number of AD cases compared to the entorhinal cortex. The 
differences detected could be due to a number of different tissue factors. 
Understanding why this region has less truncated forms of Aβ peptides and less 
microglial activation may provide insight into the disease mechanism of Alzheimer’s 
disease and other neurodegenerative disorders.  
